Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

sophie_biguenet_cmo_abivax

Abivax appoints Dr Sophie Biguenet as Chief Medical Officer

March 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Clinical-stage biotechnology company Abivax has appointed Dr Sophie Biguenet as Chief Medical Officer. Dr Biguenet brings 25 years of experience …
Appointment
cov

MAPs during a global pandemic

February 26, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, MAPS

Early and managed access programmes provide opportunities for patients to get the treatments they need faster – but the COVID-19 …
Feature

How COVID-19 has changed pharmacovigilance

February 26, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, pharmacovigilance

The race to provide vaccines and treatments for coronavirus has seen a number of COVID-19 drugs reach the market in …
Feature

UC San Diego School of Medicine researchers treat atopic dermatitis with bacteriotherapy

February 24, 2021 Research and Development atopic dermatitis, eczema

Researchers at the University of California San Diego School of Medicine have identified a universal strain of bacteria derived from …
News

Sanofi and SIRION collaborate on AAV vector development to treat serious diseases

February 24, 2021 Research and Development AAV vectors, SIRION, Sanofi

SIRION Biotech and Sanofi have entered into an agreement to develop effective medicines for illnesses impacting major human organs.
News
cervical dysplasia

QIAGEN and INOVIO to develop diagnostic tests for cervical dysplasia treatment

February 24, 2021 Research and Development Inovio, Qiagen, cervical dysplasia

QIAGEN and INOVIO Pharmaceuticals have extended their collaboration to develop a new diagnostic test which identifies the women most likely …
News
bluebird_bio_external_durham_nc_manufacturing

FDA halts studies for bluebird bio’s sickle cell therapy LentiGlobin

February 24, 2021 Research and Development Bluebird Bio, FDA, sickle cell disease

The FDA has put bluebird bio’s LentiGlobin gene therapy programme for sickle cell disease (SCD) on clinical hold, following Suspected …
News
opaganib-bottle-and-tablets

RedHill Biopharma to expand COVID-19 opaganib trial to US

February 24, 2021 Research and Development COVID-19, RedHill Biopharma

RedHill Biopharma has announced its plans to expand the company’s global Phase II/III study of opaganib in patients with severe …
News
covid-19 virus

Pharmafile.com’s weekly COVID-19 news round-up

February 17, 2021 Research and Development COVID-19, COVID-19 vaccine, Vaccine, World Health Organisation, covid-19 roundup

The past week has continued to see positive COVID-19 vaccine news; a WHO panel approved the Oxford-AstraZeneca vaccine for all …
News

J&J’s one-shot COVID-19 vaccine submitted to the EU

February 17, 2021 Research and Development COVID, COVID Vaccine, COVID-19, Johnson & Johnson, Vaccine

Johnson & Johnson has applied to the EMA for marketing authorisation of their one-shot COVID-19 vaccine in Europe.
News
lynparza

AstraZeneca and MSD’s Lynparza crosses superiority boundary for invasive disease-free survival

February 17, 2021 Research and Development AstraZeneca, Cancer, MSD

The OlympiA Phase III trial for AstraZeneca and MSD’s cancer drug Lynparza will move to early primary analysis and reporting, …
News

Novartis and Gates Foundation join forces on sickle cell disease research

February 17, 2021 Research and Development Novartis, sickle cell disease

Novartis has entered into a grant agreement with the Bill & Melinda Gates Foundation, under which the foundation will fund …
News

FDA approves Novartis’ heart failure drug Entresto

February 17, 2021 Research and Development FDA, Novartis

The FDA has approved Novartis’ Entresto (sacubitril/valsartan) to reduce the risk of cardiovascular death and hospitalisation for heart failure in …
News
elizabeth_crain

Exscientia appoints Moelis & Company COO Elizabeth Crain to Board of Directors

February 10, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

AI-driven pharma-tech company Exscientia has appointed Elizabeth Crain to their Board of Directors.
Appointment

Accure Therapeutics’ drug candidate can slow epilepsy progression, study shows

February 10, 2021 Research and Development epilepsy

Accure Therapeutics, an R&D pharmaceutical company in the central nervous system (CNS) field, has announced the publication of a pivotal …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026